Mizuho upgraded Ameren from Neutral to Outperform and set a new price target of $89.00 from $82.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/25/2025 | $100.00 | Sell → Neutral | Goldman |
| 5/14/2025 | $103.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 1/27/2025 | $88.00 → $95.00 | Overweight → Equal Weight | Barclays |
| 1/21/2025 | $89.00 → $104.00 | In-line → Outperform | Evercore ISI |
| 9/20/2024 | $97.00 | Buy | Jefferies |
| 9/16/2024 | $82.00 → $89.00 | Neutral → Outperform | Mizuho |
| 7/19/2024 | $81.00 → $87.00 | Buy | UBS |
| 5/30/2024 | $73.00 → $77.00 | Equal Weight → Overweight | Barclays |
11-K - AMEREN CORP (0001002910) (Filer)
8-K - AMEREN CORP (0001002910) (Filer)
SCHEDULE 13G/A - AMEREN CORP (0001002910) (Subject)